Skip to content

Clinical trials

Phase 2 Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2 Country / region: Russia Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20052
20064
20072
20083
20091
20103
20112
20123
20141
20153
20162
20171
20182
20193
20212
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated9
Active, not recruiting4
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Institut de Recherches Internationales Servier4
Bayer3
GlaxoSmithKline3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Pfizer3
Blokhin's Russian Cancer Research Center2
Gilead Sciences2
Novartis Pharmaceuticals2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms43
Neoplasm Metastasis9
Carcinoma, Non-Small-Cell Lung8
Breast Neoplasms7
Colorectal Neoplasms7
Lung Neoplasms5
Ovarian Neoplasms3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Recurrence3
Bronchial Neoplasms2

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.